Source: European Medicines Agency (EU) Revision Year: 2021 Publisher: Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium
Staquis 20 mg/g ointment.
| Pharmaceutical Form |
|---|
|
Ointment. White to off-white ointment. |
One g of ointment contains 20 mg of crisaborole.
Excipients with known effect:
Propylene glycol, 90 mg/g of ointment.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Crisaborole |
Crisaborole is an anti-inflammatory benzoxaborole phosphodiesterase-4 (PDE4) inhibitor that suppresses secretion of certain cytokines, such as tumour necrosis factor-α (TNF-α), interleukins (IL-2, IL-4, IL-5), and interferon gamma (IFNγ), and improves skin barrier function as measured by transepidermal water loss (TEWL). It is used for treatment of mild to moderate atopic dermatitis in adults and paediatric patients. |
| List of Excipients |
|---|
|
Paraffin, white soft |
Multi-layered laminate tube with a high density polyethylene tube head with a peel seal, and a white polypropylene cap closure. The exterior layer of the tube consists of seven layers (low-density polyethylene, white high-density polyethylene, high-density polyethylene, low-density polyethylene, ethylene-acrylic acid, foil, and ethylene-acrylic acid). The inner lining consists of linear low-density polyethylene.
Tubes of 2.5 g, 30 g, 60 g, and 100 g. Six tubes per carton for the 2.5 g tubes. One tube per carton for the 30 g, 60 g, and 100 g tubes.
Not all tube sizes may be marketed.
Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium
EU/1/19/1421/001
EU/1/19/1421/002
EU/1/19/1421/003
EU/1/19/1421/004
Date of first authorisation: 27 March 2020
| Drug | Countries | |
|---|---|---|
| STAQUIS | Austria, Estonia, Hong Kong, Israel, Lithuania, Poland, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
